Skip to main content

The epidemiological and economic burden of diabetes and health policy in different health care systems

Published in Globalization and Health

© AndreyPopov / Getty Images / iStockEdited by Dr Panos Kanavos and Ms Alessandra Ferrario, London School of Economics and Political Science, United Kingdom

As chronic a disease, diabetes is increasingly recognized to be a major contributor to the global burden of disease in both rich and poor countries. An investigation of the impact of, and response of national health health care systems to, diabetes is therefore appropriately in the spotlight. This special issue is a collection of papers that consider the epidemiological and economic burden and health policy options across a range of countries and illustrates the variety and complexity of the problems posed by this growing epidemic as well as some of the more innovative national responses and lessons learned.

The series was funded by an unrestricted educational grant from Novo Nordisk.

  1. Diabetes and its complications are a major cause of morbidity and mortality in India, and the prevalence of type 2 diabetes is on the rise. This calls for an assessment of the economic burden of the disease.

    Authors: Charles AK Yesudian, Mari Grepstad, Erica Visintin and Alessandra Ferrario
    Citation: Globalization and Health 2014 10:80
  2. Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better ...

    Authors: Larbi Lamri, Erofile Gripiotis and Alessandra Ferrario
    Citation: Globalization and Health 2014 10:11
  3. The objective of this review was to describe and situate the burden and treatment of diabetes within the broader context of the French health care system.

    Authors: Karine Chevreul, Karen Berg Brigham and Clara Bouché
    Citation: Globalization and Health 2014 10:6
  4. The expanding diabetes epidemic worldwide could have potentially devastating effects on the development of healthcare systems and economies in emerging countries, both in terms of direct health care costs and ...

    Authors: Pradana Soewondo, Alessandra Ferrario and Dicky Levenus Tahapary
    Citation: Globalization and Health 2013 9:63
  5. With an estimated 74% of all deaths attributable to non-communicable diseases (NCDs) in 2010, NCDs have become a major health priority in Brazil. The objective of the study was to conduct a comprehensive liter...

    Authors: Andréa D Bertoldi, Panos Kanavos, Giovanny V A França, André Carraro, Cesar Augusto Ovieda Tejada, Pedro C Hallal, Alessandra Ferrario and Maria Inês Schmidt
    Citation: Globalization and Health 2013 9:62
  6. Diabetes is an expensive disease in Argentina as well as worldwide, and its prevalence is continuously rising affecting the quality of life of people with the disease and their life expectancy. It also imposes...

    Authors: Joaquín E Caporale, Jorge F Elgart and Juan J Gagliardino
    Citation: Globalization and Health 2013 9:54
  7. Diabetes is becoming of increasing concern in Spain due to rising incidence and prevalence, although little information is known with regards to costs and outcomes. The information on cost of diabetes in Spain...

    Authors: Julio Lopez-Bastida, Mauro Boronat, Juan Oliva Moreno and Willemien Schurer
    Citation: Globalization and Health 2013 9:17
  8. Diabetes and its complications are among the present and future challenges of the Turkish health care system. The objective of this paper is to discuss the current situation of diabetes and its management in T...

    Authors: Mehtap Tatar
    Citation: Globalization and Health 2013 9:16
  9. Mexico has been experiencing some of the most rapid shifts ever recorded in dietary and physical activity patterns leading to obesity. Diabetes mellitus has played a crucial role causing nearly 14% of all deat...

    Authors: Simon Barquera, Ismael Campos-Nonato, Carlos Aguilar-Salinas, Ruy Lopez-Ridaura, Armando Arredondo and Juan Rivera-Dommarco
    Citation: Globalization and Health 2013 9:3